Celldex Therapeutics, Inc. · NASDAQ:CLDX

Bellevue Group AG reported a 5.40% stake in Celldex Therapeutics, Inc. (Schedule 13G)

Event Aug 18, 2025 · Filed Nov 14, 2025

Bellevue Group AG reported a 5.40% stake in Celldex Therapeutics, Inc., 3,617,669 shares, as a passive investor on Aug 18, 2025. Filed Nov 14, 2025 (Schedule 13G).

Stake
5.40%
Shares
3,617,669
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Bellevue Group AG5.40%3,617,669
Bellevue Asset Management AG5.40%3,617,669

Source

View original at SEC

Related